IP Library Assignment 037512/0596
Patent Assignment
Reel/Frame 037512/0596

Change of Name

Recorded: 2016-01-13 Pages: 4
Assignor
NEOPROBE CORPORATION
Executed: 2011-12-13
Assignee
NAVIDEA BIOPHARMACEUTICALS, INC.
5600 BLAZER PARKWAY, SUITE 200, DUBLIN, OHIO, 43017
Covered Property (1)
Compositions for Radiolabeling Diethylenetriaminepentaacetic Acid (Dtpa)-Dextran
Patent: 9,439,985 →
Application: 14/039,648 →
Publication: US 2014/0023586
Related Assignments (4)
Other recorded transfers of the patent in this record — the chain of ownership.
Security Interest May 15, 2015
From: NAVIDEA BIOPHARMACEUTICALS, INC.
To: CAPITAL ROYALTY PARTNERS II L.P.; CAPITAL ROYALTY PARTNERS II - PARALLEL FUND "A" L.P.; PARALLEL INVESTMENT OPPORTUNITIES PARTNERS II L.P.
Reel/Frame 035653/0441 →
Assignment of Assignor's Interest Jan 13, 2016
From: MAGNESON, GERALD R.; ORAHOOD, RICHARD C.
To: NEOPROBE CORPORATION
Reel/Frame 037481/0778 →
Release of Security Interest Mar 9, 2017
From: CAPITAL ROYALTY PARTNERS II L.P.; CAPITAL ROYALTY PARTNERS II - PARALLEL FUND "A" L.P.; PARALLEL INVESTMENT OPPORTUNITIES PARTNERS II L.P.
To: NAVIDEA BIOPHARMACEUTICALS, INC.
Reel/Frame 041518/0749 →
Assignment of Assignor's Interest Mar 20, 2017
From: NAVIDEA BIOPHARMACEUTICALS, INC.
To: CARDINAL HEALTH 414, LLC
Reel/Frame 041645/0574 →